Concepedia

Robert Chen

RC

60

Publications

8.2K

Citations

39

H-Index

2009

Active since

Affiliations

City Of Hope National Medical Center(Current)

City of Hope

The University of Texas MD Anderson Cancer Center

Seagen (United States)

Memorial Sloan Kettering Cancer Center

Robert Chen is an author at City Of Hope National Medical Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2009–2023

60

Publications

60

Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

Anas Younes, Ajay K. Gopal, Scott E. Smith et al. · Journal of Clinical Oncology · 2012 · 1.5K citations · Full text

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma

Robert Chen, Pier Luigi Zinzani, Michelle A. Fanale et al. · Journal of Clinical Oncology · 2017 · 967 citations · Full text

, , +18

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

Joseph M. Connors, Wojciech Jurczak, David J. Straus et al. · New England Journal of Medicine · 2017 · 738 citations · Full text

Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Robert Chen, Ajay K. Gopal, Scott E. Smith et al. · Blood · 2016 · 389 citations · Full text

Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk

Soumya Raychaudhuri, Brian Thomson, Elaine F. Remmers et al. · Nature Genetics · 2009 · 350 citations

, , +12

Rows per page

1–5 of 60